SCHEMBL15344670

SCHEMBL15344670

Cc1ccc(S(=O)(=O)OC[C@H](CCO[Si](C)(C)C(C)(C)C)NC(=O)OC(C)(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
TSHR P16473 2/20 0.40
PLA2G2C Q5R387 1/20 0.36
LMNA P02545 4/20 0.36
HTT P42858 4/20 0.36
NPSR1 Q6W5P4 4/20 0.36
PKM P14618 3/20 0.36
XBP1 P17861 3/20 0.36
HSD17B10 Q99714 3/20 0.36
TP53 P04637 2/20 0.36
MAPK1 P28482 2/20 0.36
HSP90AA1 P07900 1/20 0.36
GAA P10253 1/20 0.36
CA2 P00918 3/20 0.36
CA1 P00915 2/20 0.36
CA9 Q16790 2/20 0.36
CA4 P22748 1/20 0.36
CA7 P43166 1/20 0.36
ATM Q13315 2/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3089832 0.83 ALDH1A1 (0.45) ALDH1A1TSHRPLA2G2CCA2CA1
SCHEMBL28968914 0.83 ALDH1A1 (0.45) ALDH1A1TSHRPLA2G2CCA2CA1
SCHEMBL12944323 0.83 ALDH1A1 (0.43) ALDH1A1TSHRPLA2G2CLMNAHTT
SCHEMBL15344686 0.82 CA1 (0.33) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL8193095 0.82 ALDH1A1 (0.43) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL384396 0.82 ALDH1A1 (0.42) ALDH1A1TSHRPLA2G2CLMNAHTT
SCHEMBL1764915 0.82 ALDH1A1 (0.42) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL1764913 0.82 ALDH1A1 (0.42) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL15627953 0.81 AAK1 (0.52) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL29255200 0.81 ALDH1A1 (0.42) ALDH1A1TSHRLMNAHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9187419-B2 Intermediates of sitagliptin and preparation process thereof ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD. (CN) 2015-11-17 US disclosed
US-20130281695-A1 INTERMEDIATES OF SITAGLIPTIN AND PREPARATION PROCESS THEREOF ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD. (CN) 2013-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281695-A1 INTERMEDIATES OF SITAGLIPTIN AND PREPARATION PROCESS THEREOF DPP4, DPP9, DPP3 ALDH1A1 2403/4885TSHR 3902/4885PLA2G2C 1851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.